PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 30, Issue 14, Pages 1670-1677

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2012-03-27

DOI

10.1200/jco.2011.38.5591

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation